Clinical Studies

Caring for our patients is our biggest priority. Our clinics offer expert services in several specialized areas of genetics. 

Angelman Syndrome Study

Ovid Therapeutics is sponsoring a clinical research study called the STARS study. The STARS study will evaluate the safety and effectiveness of an investigational medicine on various aspects associated with Angelman syndrome. The STARS study will enroll approximately 75 people in a Phase 2 double-blind placebo-controlled randomized study.

Fragile X Syndrome Program

Fragile X syndrome (FXS) is a genetic condition that causes intellectual disability, behavioral and learning challenges and various physical characteristics. Though FXS occurs in both genders, males are more frequently affected than females, and generally with greater severity

Longitudinal Studies of the Glycoproteinoses

This project seeks to obtain clinical and laboratory information about individuals affected with a glycoprotein storage disorder including aspartyglucosaminuria, fucosidosis, galactosialidosis, alpha-mannosidosis, beta-mannosidosis, mucolipidosis II, mucolipidosis III, Schindler disease, and sialidosis.

Rett Syndrome Program

Through clinical care, research, and advocacy, the Rett Syndrome and Related Disorders Program of the Greenwood Genetic Center dedicated to the benefit of all individuals and families impacted by these conditions.

Meet The Jones Family

Meet The Jones Family

The journey to becoming parents did not start as an easy one for my husband and I. We suffered the heartache of miscarriage and the unimaginable pain of burying our first born child. Our son, sweet 1 lb 1.4 ounce, 12 inches long, teeny, tiny little Joseph “Hamilton” Jones was born with spina bifida, hydrocephalus, and a heart defect. It tore our hearts out leaving the hospital without him, knowing our dreams and hope for the future were shattered. ...

In The News